Stock AnalizHealthpeak Properties, Inc. DOC
Real Estate Investment Trusts · data as of November 13, 2026
Healthpeak Properties, Inc. (DOC) is a real estate company listed in the US with a market value of about $13.8B. In the twelve months to September 30, 2026 it had revenue of $3.1B and net income of $378M, a net margin of 12.3%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (1/5).
Key numbers: a P/E of 37.0, a price to free cash flow of 22.6, 5-year revenue growth of 11% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 31% above the current price.
Score: 1.8 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year revenue growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- Positive free cash flow
- Liabilities below 60% of assets
- Pays a dividend
- Dividend 3 years in a row
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.8B | $2.7B | $2.2B | $2.1B | $1.9B | $1.6B | $1.2B | $1.2B | $1.8B | $2.1B |
| Net income | $378M | $71M | $243M | $306M | $500M | $506M | $414M | $46M | $1.1B | $414M | $628M |
| Free cash flow | $610M | $357M | $334M | $182M | -$62M | $36M | -$30M | $169M | $288M | $375M | $755M |
| EPS (diluted) | $0.54 | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 | $0.77 | $0.09 | $2.24 | $0.88 | $1.34 |
| Net margin | 12.3% | 2.5% | 9.0% | 14.0% | 24.3% | 26.7% | 25.1% | 3.7% | 89.1% | 22.4% | 29.5% |
| ROIC | — | 1.2% | 0.2% | 1.3% | 1.0% | 1.0% | -0.4% | 0.4% | 0.3% | 0.5% | 1.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 19 analysts is $22.50, 13% above the current price; targets range from $17.00 to $29.00; the consensus rating is “Buy”; expected EPS is $0.09 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Healthpeak Properties’s P/E ratio?
About 37.0, based on the last twelve months of diluted earnings per share (forward P/E about 153.7).
Is Healthpeak Properties stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 31% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Healthpeak Properties pay a dividend?
Yes. The dividend yield is about 5.99%, and it has paid dividends for 10 years in our data.
Is Healthpeak Properties a good stock to buy?
We do not give buy or sell advice. Healthpeak Properties scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.